ICH E2F DEVELOPMENT SAFETY UPDATE REPORT

Titel:
ICH E2F DEVELOPMENT SAFETY UPDATE REPORT
Herkunft/Verlag:

ICH

Inhalt:
The main focus of the DSUR is data from interventional clinical trials (referred to in this document as "clinical trials") of investigational drugs including biologicals, with or without a marketing approval, whether conducted by commercial or non-commercial sponsors.

Zurück

GMP Seminare nach Thema